Trial intelligence / Profile preview

Nesiritide vs Nitroglycerin in Acute Decompensated Heart Failure

NCT00842023Phase 4Completed

Sponsor
Western University of Health Sciences
Start
Jul 2006
Primary completion
Jul 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of nesiritide in heart failure (HF) (2 arms), sponsored by Western University of Health Sciences. Primary endpoint: Renal Function by Serum Creatinine at 48 hours. Started Jul 2006; status: completed.

02

Drugs

nesiritide
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT00842023.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00842023.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call